16912555

Pervanidou P

2006

Assessment of metabolic profile in a clinical setting.

16913553

Gillett MJ

2006

Clomiphene-associated combined hyperlipidemia: a case report.

16915000

Fl?ck CE

2006

P450 oxidoreductase deficiency: a new form of congenital adrenal hyperplasia.

16916482

Liu KE

2006

Use of metformin for ovulation induction in women who have polycystic ovary syndrome with or without evidence of insulin resistance.

16918963

Fulghesu AM

2006

Pituitary-ovarian response to the gonadotrophin-releasing hormone-agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma.

16922345

Lazarov I

2006

[Polycystic ovary syndrome--modern diagnostic criteria and therapeutic approach].

16923696

Kovo M

2006

Neonatal outcome in polycystic ovarian syndrome patients treated with metformin during pregnancy.

16925218

Eid GM

2005

Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass.

16926000

Vanky E

2006

Metformin and early pregnancy?

16927729

Harris YS

2006

An African American female with irregular menses and weight gain.

16932268

Nestler JE

2006

Is metformin or clomiphene citrate more effective for ovulation induction in polycystic ovary syndrome?

16932270

Azziz R

2006

How prevalent is metabolic syndrome in women with polycystic ovary syndrome?

16932279

Legro RS

2006

Long-term, low-dose flutamide does not cause hepatotoxicity in hyperandrogenic women.

16934298

Pakrasi PL

2006

Ovulation induction by antiestrogens in an Indian tropical vespertillionid bat, Scotophilus heathi.

16936300

Hughes C

2006

Genomic and post-genomic approaches to polycystic ovary syndrome--progress so far: Mini Review.

16938614

Murphy CS

2006

Idiopathic ovarian vein thrombosis: a rare cause of abdominal pain.

16940441

Welt CK

2006

Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations.

16940454

Cascella T

2006

Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome.

16940456

Azziz R

2006

Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.

16943580

Zhang YF

2006

Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome.

16950230

Joffe H

2006

Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report.

16950750

Fleming R

2006

The use of insulin sensitising agents in ovulation induction in women with polycystic ovary syndrome.

16951267

Barutcuoglu B

2006

Increased serum neopterin levels in women with polycystic ovary syndrome.

16956601

Mlinar B

2007

Molecular mechanisms of insulin resistance and associated diseases.

16959589

Srikanthan P

2006

Polycystic ovarian syndrome: the next cardiovascular dilemma in women?

16963034

Legro RS

2006

The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects.

16963041

Ucar B

2006

Plasma adrenomedullin levels in patients with polycystic ovary syndrome.

16965825

Kolbus A

2007

Interleukin-1 alpha but not interleukin-1 beta gene polymorphism is associated with polycystic ovary syndrome.

16968464

Diamanti-Kandarakis E

2006

Inflammatory and endothelial markers in women with polycystic ovary syndrome.

16970035

Boulard S

2006

A case of trisomy 12 mosaicism with pituitary malformation and polycystic ovary syndrome.

16971221

Baravalle C

2006

Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat.

16972044

M?hlig M

2006

Predicting impaired glucose metabolism in women with polycystic ovary syndrome by decision tree modelling.

16972071

Kurioka H

2007

Glucose intolerance in Japanese patients with polycystic ovary syndrome.

16972862

Wijeyaratne CN

2006

Metabolic and polycystic ovary syndromes in indigenous South Asian women with previous gestational diabetes mellitus.

16972863

Broekmans FJ

2006

PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.

16973313

Milewicz A

2007

Clinical aspects of obesity in the gynecological endocrinologicaly practice.

16973397

Rossin-Amar B

2006

[How to improve IVF results from a clinical point of view?].

16979812

Meczekalski B

2007

Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.

16981858

L?fgren E

2006

Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy.

16982596

Essah PA

2004

The pathophysiology of miscarriage in women with polycystic ovary syndrome. Review and proposed hypothesis of mechanisms involved.

16982599

Cheang KI

2004

A Paradox: the roles of inositolphosphoglycans in mediating insulin sensitivity and hyperandrogenism in the polycystic ovary syndrome.

16984519

Demirturk F

2006

Effects of ovarian drilling in middle Black Sea region Turkish women with polycystic ovary syndrome having normal and high body mass indices.

16985482

Popovska-Dimova Z

2006

The frequency of insulin resistance calculated upon the basis of a fasting glucose to insulin ratio and characteristics of insulin resistant women with polycystic ovary syndrome.

16986497

Rastol'tsev KV

2006

[Ovarian follicular cysts in a 3-month girl].

16987685

Bennet A

2006

[Rotterdam consensus in adolescent girls: which investigations and how to interpret them to make the diagnosis of PCOS? Gynecol Obstet Fertil 2006;34:341-6].

16996195

Kasperlik-Za?uska AA

2007

Severe virilisation in a 71-year-old acromegalic woman with probable polycystic ovary syndrome.

16997933

Wu R

2007

Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome.

16997944

Moreira SN

2006

Incorporating qualitative approaches is the path to adequate understanding of the psychosocial impact of polycystic ovary syndrome.

16998724

Bilo L

2006

Epilepsy and polycystic ovary syndrome: where is the link?

17000514

Banerjee A

2006

Luteoma of pregnancy.

17000520

Jothilakshmi PK

2006

Acute alopecia due to metformin treatment for polycystic ovarian syndrome.

17001470

Tan BK

2006

Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome.

17002937

Setji TL

2006

Diagnosis of mosaic Turner's syndrome in a middle-aged woman.

17003085

Welt CK

2006

Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features.

17003086

Tan BK

2006

Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin.

17003323

Elhadd TA

2006

Ovarian stockpiling in polycystic ovary syndrome, infertility, and the combined use of rosiglitazone and metformin.

17004997

Lowenstein EJ

2006

Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome.

17007847

Siebert TI

2006

Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review.

17008325

Avellaira C

2006

Expression of molecules associated with tissue homeostasis in secretory endometria from untreated women with polycystic ovary syndrome.

17009635

Iatrakis G

2006

Women younger than 50 years with endometrial cancer.

17010975

Lanham MS

2006

Contemporary medical therapy for polycystic ovary syndrome.

17012110

Artini PG

2006

Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.

17020657

Bieniasz J

2006

[Causes of menstrual disorders in adolescent girls--a retrospective study].

17022982

van Wely M

2006

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome.

17023489

Amer SA

2007

Effect of laparoscopic ovarian diathermy on circulating inhibin B in women with anovulatory polycystic ovary syndrome.

17027360

Dahan MH

2006

Serum sex hormone-binding globulin levels show too much variability to be used effectively as a screening marker for insulin resistance in women with polycystic ovary syndrome.

17030058

Villavicencio A

2007

Deregulation of tissue homeostasis in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.

17035653

Hoppin AG

2006

Case records of the Massachusetts General Hospital. Case 31-2006. A 15-year-old girl with severe obesity.

17037948

Mastorakos G

2006

Polycystic ovary syndrome in adolescents: current and future treatment options.

17040278

Yildirir A

2006

Heart rate variability in young women with polycystic ovary syndrome.

17044949

Himelein MJ

2006

Polycystic ovary syndrome and mental health: A review.

17049715

N?cul AP

2007

Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity.

17053004

Belosi C

2006

Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?

17053375

Schneider JG

2006

The metabolic syndrome in women.

17054468

Davis JR

2006

Fetal gonadotrope cell origin of FSH-secreting pituitary adenoma - insight into human pituitary tumour pathogenesis.

17054469

Sorensen MB

2006

Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors.

17055707

Nasiek M

2007

Acute phase proteins: C-reactive protein and fibrinogen in young women with polycystic ovary syndrome.

17055812

Practice Committee of the American Society for Reproductive Medicine.

2006

Current evaluation of amenorrhea.

17055827

Practice Committee of the American Society for Reproductive Medicine.

2006

Use of insulin sensitizing agents in the treatment of polycystic ovary syndrome.

17055833

Practice Committee of the American Society for Reproductive Medicine.

2006

The evaluation and treatment of androgen excess.

17057397

Sarac F

2007

Assessment of insulin resistance in the idiopathic hirsutism.

17057614

Lornage J

2006

[In vitro maturation: the French experience].

17057616

Machelon V

2006

[Granulosa cells as indicators of oocyte quality].

17058838

Tao LL

2006

[Effects of modified longdan xiegan decoction on hyperandrogenism in patients with polycystic ovary syndrome of stagnant fire in Gan channel type].

17058987

Milke Garc?a Mdel P

2005

[Ghrelin: beyond hunger regulation].

17059392

Brinkworth GD

2006

Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.

17059974

Homko CJ

2006

Women and diabetes.

17060370

Manno M

2007

Polycystic ovary-related miscarriage: should metformin be proposed to such frustrated women?

17060537

Alvarez-Blasco F

2006

Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.

17061445

Ben Salem Hachmi L

2006

[Hypertension in polycystic ovary syndrome].

17062583

Ib??ez L

2007

Polycystic ovaries after precocious pubarche: relation to prenatal growth.

17062762

Berneis K

2007

Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome.

17062763

Cort?n M

2007

Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome.

17062765

Pellatt L

2007

Granulosa cell production of anti-M?llerian hormone is increased in polycystic ovaries.

17062769

Cust AE

2007

Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.

17062894

Hahn S

2006

The CC genotype of the GNAS T393C polymorphism is associated with obesity and insulin resistance in women with polycystic ovary syndrome.

17062953

Xiao SS

2006

[Peritoneal fluid leptin concentration and endocrine hormone in patients with polycystic ovarian syndrome].

17064547

Chen ZJ

2006

[Successful clinical pregnancy of cryopreserved human oocytes after vitrification].

17065702

Botella-Carretero JI

2006

Mutations in the hereditary hemochromatosis gene are not associated with the increased body iron stores observed in overweight and obese women with polycystic ovary syndrome.

17067587

Dokras A

2006

Obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome.